Tauriga Sciences Inc (fka TAUG)

[2bStealthy]

bolds are mine...
Transgenic microbes with an altered electrogenic efficacy, biofilms comprising such microbes, and microbial fuel cells comprising such microbes are provided. The microbial fuel cells can be operated as monitors, filtration devices, and sensors.

Claims


That which is claimed:

1. A transgenic Pseudomonas aeruginosa cell stably transformed with an isolated nucleic acid molecule that disrupts an endogenous nucleotide sequence of interest selected from the group comprising pilT (SEQ ID NO:1), pilA (SEQ ID NO:2), nirS (SEQ ID NO:3), bdlA (SEQ ID NO:4), lasI (SEQ ID NO:5), lasR (SEQ ID NO:6), ftsZ (SEQ ID NO:7), and fliC (SEQ ID NO:8) wherein said microbial cell exhibits decreased expression of said endogenous nucleotide sequence of interest and said cell exhibits an altered electrogenic efficacy.

2. The transgenic cell of claim 1, wherein at least 2 endogenous nucleotide sequences of interest are disrupted and wherein said disrupted endogenous nucleotide sequences are selected from the group comprising pilT (SEQ ID NO:1), pilA (SEQ ID NO:2), nirS (SEQ ID NO:3), bdlA (SEQ ID NO:4), lasI (SEQ ID NO:5), lasR (SEQ ID NO:6), ftsZ (SEQ ID NO:7), and fliC (SEQ ID NO:8).

3. The transgenic cell of claim 2, wherein said at least two disrupted endogenous nucleotide sequences are selected from the group of double nucleotide sequences of interest comprising pilT (SEQ ID NO:1) bdlA (SEQ ID NO:4); bdlA (SEQ ID NO:4) nirS (SEQ ID NO:3); bdlA (SEQ ID NO:4) lasI (SEQ ID NO:5); nirS (SEQ ID NO:3) pilT (SEQ ID NO:1); nirS (SEQ ID NO:3) lasI (SEQ ID NO:5); lasI (SEQ ID NO:5) pilT (SEQ ID NO:1); ftsZ (SEQ ID NO:7) pilT (SEQ ID NO:1); ftsZ (SEQ ID NO:7) bdlA (SEQ ID NO:4); ftsZ (SEQ ID NO:7) nirS (SEQ ID NO:3); and ftsZ (SEQ ID NO:7) lasI (SEQ ID NO:5).

4. The transgenic cell of claim 1, wherein said cell has a reduced proliferative capability as compared to a non-transgenic cell.

5. The transgenic cell of claim 1, wherein said cell has a reduced virulence as compared to a non-transgenic cell.

6. The transgenic cell of claim 5 wherein said reduced virulence is in mammals or plants.

7. The transgenic cell of claim 1, wherein said cell exhibits reduced motility as compared to a non-transgenic cell.

8. The transgenic cell of claim 1, wherein said cell exhibits altered pilus sticking as compared to a non-transgenic cell.

9. The transgenic cell of claim 1, wherein said cell exhibits altered twitching motility as compared to a non-transgenic cell.

10. The transgenic bacterial cell of claim 1 wherein said cell exhibits an increased current output/bacterial cell when said bacterial cell is a component of a microbial fuel cell.

11. The transgenic cell of claim 1, wherein said cell exhibits increased electron transfer to an anode.

12. The transgenic cell of claim 11, wherein said electron transfer is direct or indirect.

13. A matrix comprising a transgenic cell of claim 1.

14. The matrix of claim 13 wherein said matrix is selected from the group comprising sponges, filters, beads, powders, tissues, cassettes, cartridges, and capsules.

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,354,267.PN.&OS=PN/8,354,267&RS=PN/8,354,267